Zobrazeno 1 - 8
of 8
pro vyhledávání: '"R Todd, Plott"'
Autor:
Joel, Schlessinger, Alan, Menter, Michael, Gold, Craig, Leonardi, Lawrence, Eichenfield, R Todd, Plott, James, Leyden, Mitchell, Wortzman
Publikováno v:
Journal of drugs in dermatology : JDD. 6(6)
Clindamycin phosphate 1.2% and tretinoin 0.025% gel (CLIN/RA gel [ZIANA Gel]) is a novel topical combination agent approved by the FDA for the treatment of acne vulgaris in patients 12 years of age or older. A solution of clindamycin phosphate 1.2% c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2e1caf0de924f232f9aa757941375bd4
https://pubmed.ncbi.nlm.nih.gov/17668526
https://pubmed.ncbi.nlm.nih.gov/17668526
Autor:
R Todd, Plott, Mitchell S, Wortzman
Publikováno v:
Cutis. 78
For a long time, minocycline has been recognized as highly efficacious for the treatment of acne vulgaris but with use-limiting acute vestibular adverse events (AVAEs). Based on the concept that lowered overall systemic exposure to minocycline should
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5463183948f20fd0e3bd61afef3902c5
https://pubmed.ncbi.nlm.nih.gov/17436824
https://pubmed.ncbi.nlm.nih.gov/17436824
Publikováno v:
Cutis. 78
A multicenter, 12-week, randomized, double-blinded, placebo-controlled, dose-ranging study was conducted in 233 subjects with moderate to severe facial acne vulgaris to determine the lowest effective once-daily oral dose of a new extended-release (ER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::741c5eb5256f2bec9e9ad15d1e7a8653
https://pubmed.ncbi.nlm.nih.gov/17436825
https://pubmed.ncbi.nlm.nih.gov/17436825
Publikováno v:
Cutis. 78
The complete safety and efficacy of a new extended-release (ER) minocycline hydrochloride formulation were assessed in an analysis of a phase 2 dose-finding study and 2 phase 3 safety and efficacy studies. The studies were similar in design, subject
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc62babecd62c682d8637274d8a30316
https://pubmed.ncbi.nlm.nih.gov/17436826
https://pubmed.ncbi.nlm.nih.gov/17436826
Publikováno v:
Archives of dermatology. 142(12)
Objective To assess the potential of a superhigh-potency 0.1% fluocinonide cream to suppress the hypothalamic-pituitary-adrenal (HPA) axis in pediatric patients with atopic dermatitis. Design A multicenter, multiple-dose, open-label safety study in 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd15edc25fd62aeaddec94843f3e4d21
https://pubmed.ncbi.nlm.nih.gov/18025377
https://pubmed.ncbi.nlm.nih.gov/18025377
Publikováno v:
Archives of Dermatology. 130:890
Background: Immunotherapy with recombinant interleukin 2 may result in regression of metastatic cancer, particularly malignant melanoma and renal cell carcinoma. Observations: We describe a patient who received interleukin 2 immunotherapy for metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f1d135e34502d0595b87e20ee35ec7e
https://doi.org/10.1001/archderm.1994.01690070084013
https://doi.org/10.1001/archderm.1994.01690070084013
Publikováno v:
Journal of Dermatological Science. 6:50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6956b9c046e6bc9037221d3d9a697486
https://doi.org/10.1016/0923-1811(93)91002-c
https://doi.org/10.1016/0923-1811(93)91002-c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.